Market Access & Pricing Strategy

What Market Access & Pricing Strategy does

Market Access & Pricing Strategy (MArS) is a Weil Am Rhein, Germany-based private consultancy and SaaS provider founded in 2012, serving pharmaceutical, biotech, and medical device companies navigating market access and reimbursement in the D-A-CH region and internationally. The company operates a dual model: a hands-on consultancy offering virtual market access team services, dossier creation, payer negotiations, and direct contracting with German health insurance funds; and a productized AI platform portfolio comprising five tools — mAxInsights (AI market access planning), DO-Bo (a closed language model–based AI medical writing bot for AMCP, EU joint HTA, and AMNOG dossiers), Q-BO (AI sales and negotiation training), Wafle (VR + AI role-play training), and evin hub (real-world data analytics). The consultancy is regionally focused on D-A-CH, while the SaaS platforms are positioned for global rollout, currently covering Europe and the United States with additional countries being implemented. Revenue is generated through professional services engagements and subscription-based platform access, with pricing opaque and quote-based across both streams. The company is privately held, small (11–50 employees), and shows no public funding or acquisition history; its recent strategic posture emphasizes productization of AI tools, geographic expansion of the SaaS layer, and extension into adjacent verticals such as real-world evidence analytics and immersive enterprise training.

Name

Market Access & Pricing Strategy

Website

https://marketaccess-pricingstrategy.de

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Market Access & Pricing Strategy (MArS) is a Germany-based consultancy and SaaS provider that combines hands-on D-A-CH market access advisory with five AI-powered platforms (mAxInsights, DO-Bo, Q-BO, Wafle, evin hub) serving pharmaceutical, biotech, and medical device companies on reimbursement, dossier writing, training, and real-world data analytics.

Ownership category

akta.pro rank

Product category

Pharmaceutical Market Access Consulting

NAICS

Software Publishers (5132), Custom Computer Programming Services (541511), Computer Systems Design and Related Services (54151)

SIC

Services-Computer Programming, Data Processing, Etc. (7370), Services-Prepackaged Software (7372), Services-Health Services (8000)

akta.pro primary industry

Medication Pricing, Copay Assistance & Patient Financial Support Tools (HLACAKAN)

akta.pro secondary industry

Payer-Provider Data Exchange (X12, prior auth, claims/clinical attachment) (HLACABAK)

Keywords

• Market access consulting
• Reimbursement dossiers
• Healthcare pricing strategy
• Health economics advisory
• Market access planning

Headquarters

HQ city

Weil Am Rhein

HQ country

Germany

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Market Access Consultancy: Hands-on consultancy services for market access in Germany, Austria, and Switzerland, including virtual market access team services, payer advising, dossier creation, negotiations, and direct contracting with health insurance funds.
2. AI SaaS Platforms (mAxInsights, DO-Bo, Q-BO, Wafle, Evin Hub): Subscription-based access to AI-powered platforms for market access planning, dossier writing, sales training, and real-world data analysis. Tools accessible to startups, accelerators, and established companies.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

MArS delivers healthcare market access and pricing strategy consultancy for the D-A-CH region (Germany, Austria, Switzerland), including virtual market access team services, payer advising, dossier creation, negotiations, and direct contracting with health insurance funds. Alongside the consultancy, the company offers five AI-powered software products: mAxInsights (AI market access planning), DO-Bo (AI medical writing bot for reimbursement dossiers), Q-BO (AI sales/negotiation training), Wafle (VR and AI immersive training), and evin hub (real-world healthcare data analysis).

Product overview

Market Access & Pricing Strategy (MArS) offers a platform-plus-modules architecture consisting of five core AI-powered products: mAxInsights (AI-based market access planning tool), DO-Bo (AI medical writing bot for reimbursement dossiers), Q-BO (AI-based sales and negotiation training platform), Wafle (VR and AI training platform), and evin hub (real-world data analysis platform). These products are complemented by Market Access Consultancy services for the D-A-CH region. The portfolio covers the full spectrum of healthcare market access needs from planning and training to dossier creation and real-world data analysis.

Differentiator

Problem solved

Functional benefit

Brands

• mAxInsights: AI-based global market access planning tool for healthcare companies to enter new markets quickly and effectively, offering quick clinical assessment, reimbursement codes and epidemiology, and reimbursement process per country. Currently available for Europe and the United States.
• DO-Bo
• Q-BO
• Wafle
• evin hub (RWD)

Products and services

• mAxInsights AI-based global market access planning tool that provides quick clinical assessment, reimbursement codes and epidemiology data, and reimbursement process guidance per country. Accessible to startups, accelerators, and established healthcare companies.
• DO-Bo AI medical writing bot that creates reimbursement dossier versions for the US (AMCP), Europe (EU joint HTA), and Germany (AMNOG) within minutes after document upload, operating in a secured and closed back-end.
• Q-BO AI-based training platform using exposure therapy concepts that lets users upload content and engage in individual learning sessions via text or audio, with per-action and overall performance scoring.
• Wafle VR and AI training platform that simulates real-life interactions with healthcare professionals and payers, navigates compliance guidelines, and uses AI-driven analytics to tailor individual learning paths across compliance, key accounts, and sales disciplines.
• evin hub (RWD) Real-world healthcare data analysis platform that provides insights from RWD to close knowledge gaps and drive innovation, supporting the full research workflow from planning through publishing.
• Market Access Consultancy Strategic consultancy services for the D-A-CH region, including virtual market access team support, payer advising, dossier creation, negotiations, and direct contracting with individual health insurance funds in Germany.

Quantifiable outcome

• Dossier versions available within minutes after document upload

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability11 records

Feature5 records

Scale indicators1 record

Recent moves6 records

Expansion highlights6 records

Direct peers

• Xcenda (Cencora): Market access, HEOR, and payer consulting arm of Cencora, focused on manufacturer services across US and Europe. Directly comparable to MArS's pricing, reimbursement, and dossier work.
• Lumanity: Healthcare consultancy formed from the merger of several market access and HEOR firms, providing payer engagement, pricing, and evidence services. Comparable to MArS's D-A-CH/EU pricing and market access work.
• Evidera (PPD/Thermo Fisher): Market access, health economics, and outcomes research consultancy serving global pharma, biotech, and device companies. Directly comparable to MArS's consultancy and dossier/RWE work, with significantly larger global scale.
• ZS Associates: Global consulting firm with deep pharma sales, marketing, and market access practices, plus proprietary AI/analytics assets. Comparable on the consultancy-plus-AI platform model and target customer set.
• Axtria: Data analytics and AI software company focused on life sciences commercial and market access workflows. Closely comparable to MArS in combining AI tools with domain consulting, particularly in payer and provider engagement.
• Trinity Life Sciences: Life sciences strategy and insights firm with strong market access, pricing, and evidence capabilities. Overlaps directly with MArS's pricing strategy, payer advisory, and dossier offerings.
• Cytel: Biostatistics and HEOR/market access consultancy serving pharma, with software-enabled offerings. Comparable to MArS in health economics, RWE, and pricing strategy domains.

Broad incumbents

• IQVIA: Largest life sciences services and data platform globally, with broad market access, RWE, and commercial analytics offerings. Overlaps with nearly every MArS capability but as part of a much wider portfolio.
• Veeva Systems: Life sciences cloud platform covering commercial, medical, and regulatory workflows. Adjacent to MArS's AI tools for dossier and commercial content, though it is a broader enterprise platform.

Emerging players

• Indegene: AI-driven life sciences commercialization company offering content, medical affairs, and market access services. Comparable as a tech-first challenger combining AI tooling with pharma commercial expertise.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Market Access & Pricing Strategy